International Parkinson Disease Genomics Consortium (IPDGC)
United States of America (USA)
1 December 2019 - 30 November 2020
Research collaboration: International Parkinson Disease Genomics Consortium (IPDGC) is a research collaboration whose article contributions are accrued to its participating partner institutions.
International Parkinson Disease Genomics Consortium (IPDGC)
Partner Institutions
International Parkinson Disease Genomics Consortium (IPDGC) is a research collaboration whose article contributions are accrued to its participating partner institutions below.
- NIH National Institute on Aging (NIA), United States of America (USA)
- UCL Queen Square Institute of Neurology (IoN), United Kingdom (UK)
- Université Toulouse III - Paul Sabatier (UPS), France
- University of Tübingen (Uni Tübingen), Germany
- deCODE Genetics, Inc., Iceland
- Washington University School of Medicine (WUSM), WUSTL, United States of America (USA)
- Research Center of the Brain and Spinal Cord Institute (CRISM), ICM, France
- AP-HP Pitié-Salpêtrière Hospital - Charles-Foix, France
- UCL Genetics Institute (UGI), United Kingdom (UK)
- Physiopathology Center of Toulouse-Purpan (CPTP), France
- VU University Medical Center (VUmc), Netherlands
- Landsptali University Hospital, Iceland
- Mid Essex Hospital Services NHS Trust, United Kingdom (UK)
- Addenbrooke's Hospital, United Kingdom (UK)
- University of Cambridge, United Kingdom (UK)
- University of Bristol (UoB), United Kingdom (UK)
- University of Amsterdam (UvA), Netherlands
- Massachusetts General Hospital (MGH), United States of America (USA)
- Radboud University Medical Centre (Radboudumc), RU, Netherlands
- Newcastle University, United Kingdom (UK)
- University of Birmingham (UB), United Kingdom (UK)
- University of Aberdeen, United Kingdom (UK)
- University Hospital Nantes (CHU de Nantes), France
- Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED), Université de Bordeaux, France
- Wellcome Sanger Institute, United Kingdom (UK)
- University of Kiel (CAU), Germany
- Imperial College London (ICL), United Kingdom (UK)
- CHU Clermont-Ferrand, France
- John van Geest Centre for Brain Repair (BRC), University of Cambridge, United Kingdom (UK)
- Leiden University, Netherlands
- AARP, Inc., United States of America (USA)
- John Radcliffe Hospital, United Kingdom (UK)
- The Pennsylvania State University (Penn State), United States of America (USA)
- Helmholtz Zentrum München - German Research Center for Environmental Health (HMGU), Germany
- Public Health and Molecular Epidemiology of Aging-related Diseases, France
- NIH National Human Genome Research Institute (NHGRI), United States of America (USA)
- MRC Centre for Neuropsychiatric Genetics and Genomics (CNGG), Cardiff University, United Kingdom (UK)
- National Hospital for Neurology and Neurosurgery (NHNN), UCLH, United Kingdom (UK)
- Washington University in St. Louis (WUSTL), United States of America (USA)
- Alps Grenoble University Hospital (CHU Grenoble Alpes), France
- Biogen Inc., United States of America (USA)
- Erasmus University Medical Center (Erasmus MC), Netherlands
- University of Rochester (UR), United States of America (USA)
- The University of Edinburgh, United Kingdom (UK)
- Oxford Wellcome Trust Centre for Human Genetics, United Kingdom (UK)
- The Parkinson's Institute and Clinical Center (The PI), United States of America (USA)
- CHU de Bordeaux, France
- Institut Pasteur de Lille (Pasteur-Lille), France
- Sandwell and West Birmingham Hospitals NHS Trust (SWBH), United Kingdom (UK)
- University Hospitals Birmingham NHS Foundation Trust (UHB), United Kingdom (UK)
- Broad Institute of MIT and Harvard, United States of America (USA)
- German Center for Neurodegenerative Diseases within the Helmholtz Association (DZNE), Germany
- Cardiff University, United Kingdom (UK)
- King Faisal Specialist Hospital and Research Centre (KFSH&RC), Saudi Arabia
- French National Centre for Scientific Research (CNRS), France
- Queen Mary University of London (QMUL), United Kingdom (UK)
- Sorbonne University, France